Internal Medicine, Hematology & Oncology · Tyler, TX
NPI
1952504045
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
721 Clinic Dr, Suite A
Tyler, TX, 75701
Phone (903) 592-6152
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
1,226 services
Medicare patients, 2024
510
Average age 75
Drug cost, 2024
$5.6M
2,779 prescriptions
Company payments, 2025
$2,301
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc E Usrey was code 99215 (office e&m - established), 389 times for 194 patients. In total Marc E Usrey billed 1,226 services in 12 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 389 | 194 | $101.88 | $40K |
| 99214 Office E&M - Established | Office | 242 | 185 | $62.31 | $15K |
| 99215 Office E&M - Established | Facility | 111 | 53 | $99.85 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 106 | 42 | $90.03 | $9,543 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 99 | 20 | $36.89 | $3,653 |
| 99205 Office E&M - New | Office | 73 | 73 | $128.61 | $9,389 |
| 99223 Hospital E&M - Initial | Facility | 41 | 38 | $128.61 | $5,273 |
| 99214 Office E&M - Established | Facility | 38 | 32 | $70.12 | $2,665 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 37 | 17 | $26.49 | $980 |
| 99232 Hospital E&M - Subsequent | Facility | 30 | 23 | $59.82 | $1,795 |
| 99213 Office E&M - Established | Office | 29 | 27 | $41.16 | $1,194 |
| 99490 Chronic, Principal, and Transitional Care Management | Facility | 11 | 11 | $38.12 | $419 |
By year: 2022 $103K for 1,245 services; 2023 $94K for 1,162 services; 2024 $102K for 1,226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc E Usrey prescribed most often to Medicare patients was Prednisone, with 305 prescriptions and refills. In total Marc E Usrey wrote 2,779 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 305 | 336 | 75 | $1,270 |
| Abiraterone Acetate Generic | 188 | 191 | 31 | $76K |
| Xarelto Rivaroxaban | 187 | 356 | 52 | $73K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 121 | 122 | 50 | $4,185 |
| Levothyroxine Sodium Generic | 95 | 149 | 22 | $619 |
| Letrozole Generic | 92 | 205 | 25 | $2,122 |
| Prochlorperazine Maleate Generic | 84 | 84 | 47 | $894 |
| Potassium Chloride Generic | 72 | 131 | 37 | $1,054 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 71 | 85 | 15 | $523 |
| Ondansetron Odt Ondansetron | 64 | 64 | 29 | $1,129 |
| Tamoxifen Citrate Generic | 64 | 149 | 19 | $1,582 |
| Dexamethasone Generic | 63 | 77 | 29 | $1,308 |
| Ondansetron Hcl Generic | 61 | 61 | 41 | $483 |
| Eliquis Apixaban | 58 | 70 | 12 | $41K |
| Acyclovir Generic | 53 | 68 | 12 | $663 |
Brand drugs: 711 claims; generic drugs: 2,068 claims; opioid claims: 222.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc E Usrey $2,301 ($2,301 in general payments such as food, travel and fees) from 38 companies. The largest payer was Abbvie Inc. with $274.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $274 |
| Tempus AI, Inc TEM | 8 | $183 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $163 |
| Janssen Biotech, Inc. JNJ | 7 | $139 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $124 |
| Pfizer Inc. PFE | 5 | $120 |
| Aveo Pharmaceuticals, Inc. | 4 | $89.12 |
| Incyte Corporation INCY | 4 | $88.8 |
| Dendreon Pharmaceuticals LLC | 4 | $87.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.